beyondbrics
The emerging markets hub
| About this blog |
Headlines email |
Blog guide |
News and comment from more than 40 emerging economies, headed by Brazil, Russia, India and China.
'Like' our
beyondbrics Facebook page, where we showcase a top story of the day
Sign up for our
news headlines and markets snaphot service. We have two emails per day - London and New York headlines (sent at approx 6am and 12pm GMT).
Pretty much
everything you need to know about beyondbrics is in our
About this site page. But briefly:
To
comment, please
register for free with FT.com and read our
policy on submitting comments.
There is an
overall beyondbrics RSS feed, as well as feeds for all our countries, tags and authors.
Learn more in our full RSS guide.
All posts are published in UK time.
Get in touch with us - your comments, advice and even complaints. Find out
how to contact the team.
See the full list of
FT blogs.
BB shortcuts
Chart of the weekBehind the numbers
Corporate watchA regular in-depth look at a significant emerging market-based company
The WeekenderCatch up with the week in emerging markets
Hello 2013
Guest posts on the outlook for the year ahead
2012 review
Quiz, charts, most read and more
BB reviewAn occasional series reviewing books and arts from around the beyondbrics world
Brics at 10A decade of growth
12 for 2012Guest writer predictions
2011 review The year in numbers
The Diaspora Digest EM diasporas, seen through their community media (Oct-Nov 2011)
Sick brics (Sep 2011)
Brics and mortar (Aug 2011)
Beyondbrics on the beach (Jul-Aug 2011)
China bubble? (June 2011)
Post-election Nigeria (June 2011)
Hey bric spender (Aug 2010)
The reputation of Chinese pharmaceuticals in Africa has taken a hammering over the last couple of years. Far from curing disease, Chinese companies are accused of sitting at the centre of a vast counterfeiting industry dumping fake medicines on the continent at a cost of billions of dollars and countless lives.
Stefan Wagstyl
Rob Minto
Pan Kwan Yuk
Jonathan Wheatley
Heba Saleh